new antiepileptic, Gabitril (tiagabine)

    Abbott is launching a new antiepileptic, Gabitril (tiagabine). It'll be used as add-on therapy to control partial seizures.

    Gabitril is thought to work by blocking the reuptake of GABA...the major inhibitory neurotransmitter in the CNS. The increased GABA levels "apply the brakes" to inhibit seizures.

    Patients use different doses of Gabitril...depending on their other antiepileptic therapy.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote